T39.8X3D — Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter
Is T39.8X3D billable?
Yes, but T39.8X3D is an unspecified code. T39.8X3D is a valid, billable ICD-10-CM code for encounters from October 1, 2026 through September 30, 2027. However, T39.8X3D is an unspecified or catch-all code. Payers apply additional scrutiny to unspecified codes and many deny them when the medical record supports a more specific option, so check the documentation before selecting T39.8X3D — the more specific alternatives are listed below.
More specific alternatives
- T39.011DPoisoning by aspirin, accidental (unintentional), subsequent encounter
- T39.1X1DPoisoning by 4-Aminophenol derivatives, accidental (unintentional), subsequent encounter
- T39.2X1DPoisoning by pyrazolone derivatives, accidental (unintentional), subsequent encounter
- T39.311DPoisoning by propionic acid derivatives, accidental (unintentional), subsequent encounter
T39.8X3D at a glance
| Code | T39.8X3D |
|---|---|
| Description | Poisoning by other nonopioid analgesics and antipyretics, not elsewhere classified, assault, subsequent encounter |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
| 7th character "D" | subsequent encounter |
What does the 7th character "D" mean in T39.8X3D?
In T39.8X3D, the 7th character D means subsequent encounter. The 7th character is required for T39.8X3D to be a valid, complete code.
Same condition, different episode of care — switch the 7th character:
Which MS-DRGs does T39.8X3D group to?
T39.8X3D sits in MDC 23 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 949Aftercare with CC/MCCmedical
- 950Aftercare without CC/MCCmedical
Excludes1 — never code together — inherited from T36-T50
The conditions below can never be reported together with T39.8X3D on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- toxic reaction to local anesthesia in pregnancy (O29.3-)
Code first — inherited from T36-T50
The underlying condition below must be sequenced before T39.8X3D. T39.8X3D describes a manifestation and cannot be the principal or first-listed diagnosis.
Use additional code — inherited from Chapter 19
Report an additional code alongside T39.8X3D to fully describe the condition. T39.8X3D is sequenced first.
- code to identify any retained foreign body, if applicable (Z18.-)
Use additional code — inherited from T36-T50
Report an additional code alongside T39.8X3D to fully describe the condition. T39.8X3D is sequenced first.
Excludes2 — not included here — inherited from Chapter 19
The conditions below are not part of T39.8X3D, but a patient may have both at the same time. When documentation supports it, T39.8X3D and the excluded code may both be reported.
Excludes2 — not included here — inherited from T36-T50
The conditions below are not part of T39.8X3D, but a patient may have both at the same time. When documentation supports it, T39.8X3D and the excluded code may both be reported.
How long has T39.8X3D existed?
T39.8X3D has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.